505 related articles for article (PubMed ID: 17122634)
41. Challenging differential diagnosis of a wild-type gastrointestinal stromal tumour (GIST) or rare reticular perineurioma of the stomach? The role for mutational analysis.
Richter KK; Dempster A; Tos AP; Premkumar R; Jackson C
N Z Med J; 2011 Mar; 124(1331):45-55. PubMed ID: 21725412
[TBL] [Abstract][Full Text] [Related]
42. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
[TBL] [Abstract][Full Text] [Related]
43. Synchronous presentation of GISTs and other primary neoplasms: a single center experience.
Arnogiannaki N; Martzoukou I; Kountourakis P; Dimitriadis E; Papathanasaki A; Nastoulis E; Gazalidou M; Fida A; Apostolikas N; Agnantis NJ
In Vivo; 2010; 24(1):109-15. PubMed ID: 20133985
[TBL] [Abstract][Full Text] [Related]
44. KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors.
Barreca A; Fornari A; Bonello L; Tondat F; Chiusa L; Lista P; Pich A
Mol Med Rep; 2011; 4(1):3-8. PubMed ID: 21461555
[TBL] [Abstract][Full Text] [Related]
45. Myxoid epithelioid gastrointestinal stromal tumor harboring an unreported PDGFRA mutation: report of a case and review of the literature.
Tajima S; Ohata A; Koda K; Maruyama Y
Int J Clin Exp Pathol; 2015; 8(5):5821-9. PubMed ID: 26191304
[TBL] [Abstract][Full Text] [Related]
46. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series.
Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM
J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398
[TBL] [Abstract][Full Text] [Related]
47. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
[TBL] [Abstract][Full Text] [Related]
48. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
[TBL] [Abstract][Full Text] [Related]
49. Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors.
Agaram NP; Baren A; Arkun K; Dematteo RP; Besmer P; Antonescu CR
Ultrastruct Pathol; 2006; 30(6):443-52. PubMed ID: 17182437
[TBL] [Abstract][Full Text] [Related]
50. KIT-positive gastrointestinal stromal tumor in a 22-year-old male chimpanzee (Pan troglodites).
Saturday GA; Lasota J; Frost D; Brasky KB; Hubbard G; Miettinen M
Vet Pathol; 2005 May; 42(3):362-5. PubMed ID: 15872385
[TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
52. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.
Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM
Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767
[TBL] [Abstract][Full Text] [Related]
53. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M; Lasota J
Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
[TBL] [Abstract][Full Text] [Related]
54. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
[TBL] [Abstract][Full Text] [Related]
55. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I
Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821
[TBL] [Abstract][Full Text] [Related]
56. Loss of DOG-1 expression associated with shift from spindled to epithelioid morphology in gastric gastrointestinal stromal tumors with KIT and platelet-derived growth factor receptor α mutations.
Agaimy A; Wang LM; Eck M; Haller F; Chetty R
Ann Diagn Pathol; 2013 Apr; 17(2):187-91. PubMed ID: 23218903
[TBL] [Abstract][Full Text] [Related]
57. Pathology of gastrointestinal stromal tumors.
Hirota S; Isozaki K
Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
[TBL] [Abstract][Full Text] [Related]
58. Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
Agaimy A; Otto C; Braun A; Geddert H; Schaefer IM; Haller F
Int J Clin Exp Pathol; 2013; 6(9):1839-46. PubMed ID: 24040448
[TBL] [Abstract][Full Text] [Related]
59. Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA.
de Raedt T; Cools J; Debiec-Rychter M; Brems H; Mentens N; Sciot R; Himpens J; de Wever I; Schöffski P; Marynen P; Legius E
Gastroenterology; 2006 Dec; 131(6):1907-12. PubMed ID: 17087943
[TBL] [Abstract][Full Text] [Related]
60. Dotlike or Golgi-like KIT and PDGFRA Staining in GISTs.
Emile JF; Stock N; Corless CL; Sciot R; Schildhaus HU; Brahimi S; Debiec-Rychter M; Wardelmann E; Coindre JM; Blay JY
Am J Surg Pathol; 2009 Jan; 33(1):157-8; author reply 157-9. PubMed ID: 18987545
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]